Pfizer/BioNTech COVID-19 vaccine offers decreased protection six months after second dose, suggests Israeli study

By | August 6, 2021
A recent study published on the preprint server medRxiv* determines whether the time elapsed since the second dose of the BNT162b2 vaccine is associated with an increased risk of breakthrough SARS-CoV-2 infection.